Key Takeaways
- Revenue for AMD's Enterprise, Embedded and Semi-Custom conception came successful supra expectations.
- The Enterprise, Embedded and Semi-Custom conception has been increasing overmuch faster than the company's different main conception arsenic processing chips are being embedded successful much and much products.
- The segment's income were partially driven by EPYC processors arsenic information halfway income much than doubled twelvemonth implicit year.
| Metric | Beat/Miss/Match | Reported Value | Analysts' Prediction |
| Adjusted EPS | Beat | $0.73 | $0.67 |
| Revenue | Beat | $4.3B | $4.1B |
| Enterprise, Embedded and Semi-Custom Segment Revenue | Beat | $1.9B | $1.8B |
Source: Predictions based connected analysts' statement from Visible Alpha
Advanced Micro Devices (AMD) Financial Results: Analysis
Advanced Micro Devices, Inc. (AMD) reported Q3 FY 2021 earnings that surpassed statement estimates. Adjusted earnings per share (EPS) bushed expectations, rising 78.0% compared to the year-ago quarter. Revenue besides exceeded expectations, up 54.0% twelvemonth implicit twelvemonth (YOY). AMD's Enterprise, Embedded and Semi-Custom conception posted gross that came successful supra forecasts.
The company's shares roseate arsenic overmuch arsenic 1% successful extended trading. Over the past year, AMD's shares person provided a total return of 49.5%, good supra the S&P 500's full instrumentality of 34.5%.
AMD Enterprise, Embedded and Semi-Custom Revenue
AMD's Enterprise, Embedded and Semi-Custom conception gross roseate 68.9% YOY, slowing from the erstwhile quarter's accelerated pace. The conception encompasses server and embedded processors, semi-custom System-on-Chip (SoC) products, improvement services, and crippled console technology. It does not see AMD's desktop and notebook microprocessors, which are included successful the company's Computing and Graphics segment.
The Enterprise, Embedded and Semi-Custom conception is the smaller of the company's 2 main segments, generating a small implicit one-third of companywide gross successful FY 2020. However, it has been increasing overmuch faster than the Computing and Graphics conception arsenic processing chips are being embedded successful much and much products.
The segment's maturation successful the 3rd 4th were fueled by income of its EPYC processors, which are utilized by information centers, and semi-custom merchandise sales. AMD said that information halfway income much than doubled compared to the year-ago quarter.
AMD Guidance
AMD expects gross to summation astir 39% YOY successful Q4 FY 2021. It besides expects yearly gross for the afloat 2021 fiscal twelvemonth to emergence astir 65%, driven by maturation crossed each of its concern segments.
AMD's adjacent net study (for Q4 FY 2021) is estimated to beryllium released connected Feb. 1, 2022.
Investopedia requires writers to usage superior sources to enactment their work. These see achromatic papers, authorities data, archetypal reporting, and interviews with manufacture experts. We besides notation archetypal probe from different reputable publishers wherever appropriate. You tin larn much astir the standards we travel successful producing accurate, unbiased contented successful our editorial policy.
Advanced Micro Devices Inc. "AMD Reports Third Quarter 2021 Financial Results," Page 1. Accessed Oct. 26, 2021.
Visible Alpha. "Financial Data." Accessed Oct. 22, 2021.
TradingView. "Price Chart: AMD and S&P 500." Accessed Oct. 26, 2021.
Advanced Micro Devices Inc. "AMD Reports Third Quarter 2021 Financial Results," Page 10. Accessed Oct. 26, 2021.
Advanced Micro Devices Inc. "Form 10-Q for the quarterly play ended June 26, 2021," Page 16. Accessed Oct. 26, 2021.
Visible Alpha. "Financial Data." Accessed Oct. 22, 2021.
Advanced Micro Devices Inc. "AMD Reports Third Quarter 2021 Financial Results," Pages 1 & 2. Accessed Oct. 26, 2021.
Advanced Micro Devices Inc. "AMD Reports Third Quarter 2021 Financial Results," Page 4. Accessed Oct. 26, 2021.
Investing.com. "Advanced Micro Devices Inc (AMD): Financials." Accessed Oct. 26, 2021.
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·